Background: Epithelial to mesenchymal transition (EMT) correlates with increased metastatic potential and poor prognosis. Results: Secreted eHsp90 induces EMT, matrix metalloproteinase activity and cell motility. Conclusion: EMT inducing activity of eHsp90 provides a mechanistic basis for its tumorigenic and metastatic function. Significance: The requirement for eHsp90 in supporting tumorigenic events indicates that targeting eHsp90 may represent a therapeutic approach to improve prostate cancer patient survival.
The hereditary breast cancer gene BRCA2 was recently cloned and is believed to account for almost half of site-specific breast cancer families and the majority of male breast cancer families. We screened 49 site-specific breast cancer families for mutations in the BRCA2 gene using single strand conformation analysis (SSCA) followed by direct sequencing. We found mutations in eight families, including all four families with male breast cancer. The eight mutations were small deletions with the exception of a single nonsense mutation, an all were predicted to interrupt the BRCA2 coding sequence and to lead to a truncated protein product. Other factors which predicted the presence of a BRCA2 mutation included a case of breast cancer diagnosed at age 35 or below (P = 0.01) and a family history of pancreatic cancer (P = 0.03). Two mutations were seen twice, including a 8535delAG, which was detected in two French Canadian families. Our results suggest the possibility that the proportion of site-specific breast cancer families attributable to BRCA2 may be overestimated.
Background: gp96 is a master chaperone for TLRs. A gp96-derived peptide (PIER) inhibits the LPS response. The underlying mechanism is unclear. Results: PIER inhibits LPS binding and signaling independently of gp96. It targets HSP90 and has anticancer activity. Conclusion: PIERs inhibit LPS responsiveness and tumor growth in a gp96-independent manner. Significance: This study facilitates the development of HSP90-based inhibitors to treat inflammation and cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.